Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stopped agonist added to GnRH antagonist cycle in poor responder women undergoing ART
IRCT20200615047779N1Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Oct 2021
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label trial of triptorelin and relugolix in infertility and poor ovarian response (POR) (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoint: Clinical pregnancy. Started Oct 2021; status: completed.
02
Drugs
triptorelinrelugolix
03
Conditions
infertilitypoor ovarian response (POR)
Beyond the preview
Go deeper on IRCT20200615047779N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200615047779N1.